DPP-4 Inhibitors for Type 2 Diabetes: Pharmacology Made Easy

In this lecture from This is Why, Dr. Busti will learn about the application of DPP-4 inhibitors in the management of type 2 diabetes mellitus (T2DM). The DPP-4 inhibitors (e.g., sitagliptin, linagliptin, saxagliptin) have an impact of incretins (GIP, GLP-1) which have continued to evolve in other treatment options.You’ll learn how to:- Mechanism of action: DPP-4 inhibition and impact on incretins (GLP-1/GIP) - Key drugs: Sitagliptin, linagliptin, saxagliptin- Clinical role: where DPP-4 inhibitors fit in type 2 diabetes treatment, including add-on therapy- Adverse effects & safety pearls: the side effects and warnings you need to know for exams and practiceThe goal = make medical education easy and clinically relevant.👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/dpp-4-inhibitors-sitagliptin-type-2-diabetes-pharmacology👉 Get more with a free membership at https://www.thisiswhy.health/- Access free downloads from our videos - Access deep dive content from Dr. Busti- Organize content via playlists & collections- Join live Q&A- Receive member newsletters- Coupons & discounts for exam prep resources👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!#dpp4inhibitors #type2diabetes #sitagliptin #diabetespharmacology #bustiDisclaimer:This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.